|
Lipids
Citations 191-200 of 397 total displayed.
|
Past content
(since Feb 1999):
|
- Clinical Investigations and Reports
Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease
- Emile R. Mohler, III, William R. Hiatt, Mark A. Creager for the Study Investigators
Circulation 2003;108:1481-1486; published online before print as doi:10.1161/01.CIR.0000090686.57897.F5
[Abstract]
[Full text]
- Articles
High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, Sally J. Leslie, William J. Sasiela, Michael Szarek, Peter Libby, Peter Ganz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published September 15, 2003, doi:10.1161/01.CIR.0000091404.09558.AF
[Abstract]
- Clinical Investigations and Reports
Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease
- Emile R. Mohler III, William R. Hiatt, Mark A. Creager for the Study Investigators
Circulation published September 2, 2003, doi:10.1161/01.CIR.0000090686.57897.F5
[Abstract]
- Clinical Investigations and Reports
Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial
- Marguerite M. Engler, Mary B. Engler, Mary J. Malloy, Elisa Y. Chiu, Monique C. Schloetter, Steven M. Paul, Markus Stuehlinger, Ken Y. Lin, John P. Cooke, Jason D. Morrow, Paul M Ridker, Nader Rifai, Elizabeth Miller, Joseph L. Witztum, and Michele Mietus-Snyder
Circulation 2003;108:1059-1063; published online before print as doi:10.1161/01.CIR.0000086345.09861.A0
[Abstract]
[Full text]
- Correspondence
Can Glucocorticoid Homeostasis Explain the Antiatherogenic Effect of Peripheral Adiposity? • Reply
- Daniel J. Brotman, John P. Girod, László B. Tankó, Yu Z. Bagger, Peter Alexandersen, Claus Christiansen, and Philip J. Larsen
Circulation 2003;108:e61, doi:10.1161/01.CIR.0000086784.14560.C3
[Full text]
- Brief Rapid Communications
Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial
- Jacqueline Saw, Steven R. Steinhubl, Peter B. Berger, Dean J. Kereiakes, Victor L. Serebruany, Danielle Brennan, and Eric J. Topol
Circulation 2003;108:921-924; published online before print as doi:10.1161/01.CIR.0000088780.57432.43
[Abstract]
[Full text]
- Articles
Lack of Adverse Clopidogrel-Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial
- Jacqueline Saw, Steven R. Steinhubl, Peter B. Berger, Dean J. Kereiakes, Victor L. Serebruany, Danielle Brennan, Eric J. Topol for the Clopidogrel for the Reduction of Events During Observation (CREDO) Investigators
Circulation published August 18, 2003, doi:10.1161/01.CIR.0000088780.57432.43
[Abstract]
- Clinical Investigations and Reports
Effect of 7-Year Infancy-Onset Dietary Intervention on Serum Lipoproteins and Lipoprotein Subclasses in Healthy Children in the Prospective, Randomized Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) Study
- Tuuli Kaitosaari, Tapani Rönnemaa, Olli Raitakari, Sanna Talvia, Katariina Kallio, Iina Volanen, Aila Leino, Eero Jokinen, Ilkka Välimäki, Jorma Viikari, and Olli Simell
Circulation 2003;108:672-677; published online before print as doi:10.1161/01.CIR.0000083723.75065.D4
[Abstract]
[Full text]
- Articles
Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia. Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial
- Marguerite M. Engler, Mary B. Engler, Mary J. Malloy, Elisa Y. Chiu, Monique C. Schloetter, Steven M. Paul, Markus Stuehlinger, Ken Y. Lin, John P. Cooke, Jason D. Morrow, Paul M Ridker, Nader Rifai, Elizabeth Miller, Joseph L. Witztum, and Michele Mietus-Snyder
Circulation published August 11, 2003, doi:10.1161/01.CIR.0000086345.09861.A0
[Abstract]
- Clinical Investigations and Reports
Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia: A Case-Control Comparison From the National Heart, Lung, and Blood Institute Family Heart Study
- Paul N. Hopkins, Gerardo Heiss, R. Curtis Ellison, Michael A. Province, James S. Pankow, John H. Eckfeldt, and Steven C. Hunt
Circulation 2003;108:519-523; published online before print as doi:10.1161/01.CIR.0000081777.17879.85
[Abstract]
[Full text]
|
|
